Research in the Howles lab is aimed at understanding the processes of cholesterol and fat absorption and metabolism. These studies are especially relevant because hyperlipidemia (e.g. high cholesterol) is a major risk factor for cardiovascular disease which remains the major cause of morbidity and mortality in the United States. Furthermore, the alarming increase of obesity and the consequent rise in Type II diabetes will present a major challenge to health care institutions in the coming decades. A complete understanding of the interplay between lipid metabolism and glucose metabolism will be critical for the development of effective therapeutic measures to both treat and prevent these diseases.
Our main project is focused on understanding the intracellular steps and cellular machinery involved in the selective uptake of cholesterol from HDL by hepatocytes and the subsequent processing of that cholesterol for secretion as biliary cholesterol, coversion to bile salts, or lipoprotein (VLDL) production. Another project is focused on the process of lipid absorption and chylomicron production by the intestinal epithelium, and the subsequent delivery of dietary fat to various tissues such as heart, muscles, fat depots, and the liver.
The first project utilizes knockout mice in which the gene for carboxyl ester lipase (CEL, cholesterol esterase, bile salt stimulated lipase) has been ablated. Absence of a functional CEL gene alters the processing of HDL-cholesterol by hepatocytes, resulting in changes in bile acid production, biliary sterol secretion, and reverse cholesterol tranport. The second project utilizes the drug ezetimibe (Zetia) and NPC1L1 knockout mice to study dietary fat and cholesterol absorption. Drug-treated and knockout mice produce intestinal lipoproteins that are dramaticlly different in size and composition, suggesting that bot the drug and the NPC1L1 protein plays an important role in chylomicron synthesis and/or secretion - most likely by affecting trafficking of cholesterol or fat to the endoplasmic reticulum or Golgi bodies. More importantly, fat carried by these chylomicrons has a different metabolic fate in drug-treated and knockout mice with subsequent effects on glucose metabolism and insulin sensitivity.
CLAS
Our lab is part of the Center for Lipid and Atherosclerosis Studies (CLAS), formerly the Lipid Research Group at the University of Cincinnati. The CLAS includes several faculty with various research projects related to the pathophysiology of lipid disorders and cardiovascular disease. Faculty, students and research staff openly share resources, skills, and ideas. Faculty and senior staff meet regularly to discuss ongoing work and to design future projects.
|
Philip N. Howles, PhD |
Dept. of Pathology North-Genome Research Institute |